Add-on Therapy With Pramipexole in Treatment Resistant Dysthymic Disorder: A Case Report [Tedaviye Dirençli Distimik Bozuklukta Pramipeksol ile Güçlendirme Tedavisi: Olgu Sunumu]
Küçük Resim Yok
Tarih
2009
Yazarlar
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Erişim Hakkı
info:eu-repo/semantics/closedAccess
Özet
Despite a wide range of alternative antidepressant drugs, a considerable rate of patients with dysthymic disorder do not response to these treatments. Usually combined pharmacological drugs and augmentation therapies are used to manage this chronic psychiatric disorder. Pramipexole, a new dopamine agonist, is approved for Parkinson's disease and restless leg syndrome but accumulating evidence suggests the usage of the drug as an antidepressant. We present a young man with a history of dysthymic disorder for 15 years who improved after adding low dose pramipexole to the prior treatment.
Açıklama
Anahtar Kelimeler
Augmentation therapies, Dysthymia, Pramipexole
Kaynak
Klinik Psikofarmakoloji Bülteni
WoS Q Değeri
Scopus Q Değeri
N/A
Cilt
19
Sayı
1
Künye
Kayhan, F., Sarı, S., Şahingöz, M., Uğuz, F., Zeytinci, E., (2009). Add-on Therapy With Pramipexole in Treatment Resistant Dysthymic Disorder: A Case Report [Tedaviye Dirençli Distimik Bozuklukta Pramipeksol ile Güçlendirme Tedavisi: Olgu Sunumu]. Klinik Psikofarmakoloji Bülteni, 19(1), 198-199.
